The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Latanoprost Market Research Report 2024
Synopsis
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
The global Latanoprost market was valued at US$ 1374.1 million in 2023 and is anticipated to reach US$ 1603.1 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
This report aims to provide a comprehensive presentation of the global market for Latanoprost, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latanoprost.
Report Scope
The Latanoprost market size, estimations, and forecasts are provided in terms of sales volume (M Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Latanoprost market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latanoprost manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Segment by Type
Brand Drug
Generic Drug
Segment by Application
Open-angle Glaucoma
Close-angle Glaucoma
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Latanoprost manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Latanoprost in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
The global Latanoprost market was valued at US$ 1374.1 million in 2023 and is anticipated to reach US$ 1603.1 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
This report aims to provide a comprehensive presentation of the global market for Latanoprost, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latanoprost.
Report Scope
The Latanoprost market size, estimations, and forecasts are provided in terms of sales volume (M Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Latanoprost market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latanoprost manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Segment by Type
Brand Drug
Generic Drug
Segment by Application
Open-angle Glaucoma
Close-angle Glaucoma
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Latanoprost manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Latanoprost in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Latanoprost Market Overview
1.1 Product Overview and Scope of Latanoprost
1.2 Latanoprost Segment by Type
1.2.1 Global Latanoprost Market Value Comparison by Type (2024-2030)
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Latanoprost Segment by Application
1.3.1 Global Latanoprost Market Value by Application: (2024-2030)
1.3.2 Open-angle Glaucoma
1.3.3 Close-angle Glaucoma
1.4 Global Latanoprost Market Size Estimates and Forecasts
1.4.1 Global Latanoprost Revenue 2019-2030
1.4.2 Global Latanoprost Sales 2019-2030
1.4.3 Global Latanoprost Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Latanoprost Market Competition by Manufacturers
2.1 Global Latanoprost Sales Market Share by Manufacturers (2019-2024)
2.2 Global Latanoprost Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Latanoprost Average Price by Manufacturers (2019-2024)
2.4 Global Latanoprost Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Latanoprost, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Latanoprost, Product Type & Application
2.7 Latanoprost Market Competitive Situation and Trends
2.7.1 Latanoprost Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Latanoprost Players Market Share by Revenue
2.7.3 Global Latanoprost Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Latanoprost Retrospective Market Scenario by Region
3.1 Global Latanoprost Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Latanoprost Global Latanoprost Sales by Region: 2019-2030
3.2.1 Global Latanoprost Sales by Region: 2019-2024
3.2.2 Global Latanoprost Sales by Region: 2025-2030
3.3 Global Latanoprost Global Latanoprost Revenue by Region: 2019-2030
3.3.1 Global Latanoprost Revenue by Region: 2019-2024
3.3.2 Global Latanoprost Revenue by Region: 2025-2030
3.4 North America Latanoprost Market Facts & Figures by Country
3.4.1 North America Latanoprost Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Latanoprost Sales by Country (2019-2030)
3.4.3 North America Latanoprost Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Latanoprost Market Facts & Figures by Country
3.5.1 Europe Latanoprost Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Latanoprost Sales by Country (2019-2030)
3.5.3 Europe Latanoprost Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Latanoprost Market Facts & Figures by Country
3.6.1 Asia Pacific Latanoprost Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Latanoprost Sales by Country (2019-2030)
3.6.3 Asia Pacific Latanoprost Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Latanoprost Market Facts & Figures by Country
3.7.1 Latin America Latanoprost Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Latanoprost Sales by Country (2019-2030)
3.7.3 Latin America Latanoprost Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Latanoprost Market Facts & Figures by Country
3.8.1 Middle East and Africa Latanoprost Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Latanoprost Sales by Country (2019-2030)
3.8.3 Middle East and Africa Latanoprost Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Latanoprost Sales by Type (2019-2030)
4.1.1 Global Latanoprost Sales by Type (2019-2024)
4.1.2 Global Latanoprost Sales by Type (2025-2030)
4.1.3 Global Latanoprost Sales Market Share by Type (2019-2030)
4.2 Global Latanoprost Revenue by Type (2019-2030)
4.2.1 Global Latanoprost Revenue by Type (2019-2024)
4.2.2 Global Latanoprost Revenue by Type (2025-2030)
4.2.3 Global Latanoprost Revenue Market Share by Type (2019-2030)
4.3 Global Latanoprost Price by Type (2019-2030)
5 Segment by Application
5.1 Global Latanoprost Sales by Application (2019-2030)
5.1.1 Global Latanoprost Sales by Application (2019-2024)
5.1.2 Global Latanoprost Sales by Application (2025-2030)
5.1.3 Global Latanoprost Sales Market Share by Application (2019-2030)
5.2 Global Latanoprost Revenue by Application (2019-2030)
5.2.1 Global Latanoprost Revenue by Application (2019-2024)
5.2.2 Global Latanoprost Revenue by Application (2025-2030)
5.2.3 Global Latanoprost Revenue Market Share by Application (2019-2030)
5.3 Global Latanoprost Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Latanoprost Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Latanoprost Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Latanoprost Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Latanoprost Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Latanoprost Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Latanoprost Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Latanoprost Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Latanoprost Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Latanoprost Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Latanoprost Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Taj Pharma
6.6.1 Taj Pharma Corporation Information
6.6.2 Taj Pharma Description and Business Overview
6.6.3 Taj Pharma Latanoprost Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Taj Pharma Latanoprost Product Portfolio
6.6.5 Taj Pharma Recent Developments/Updates
6.7 CR Zizhu
6.6.1 CR Zizhu Corporation Information
6.6.2 CR Zizhu Description and Business Overview
6.6.3 CR Zizhu Latanoprost Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CR Zizhu Latanoprost Product Portfolio
6.7.5 CR Zizhu Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Latanoprost Industry Chain Analysis
7.2 Latanoprost Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Latanoprost Production Mode & Process
7.4 Latanoprost Sales and Marketing
7.4.1 Latanoprost Sales Channels
7.4.2 Latanoprost Distributors
7.5 Latanoprost Customers
8 Latanoprost Market Dynamics
8.1 Latanoprost Industry Trends
8.2 Latanoprost Market Drivers
8.3 Latanoprost Market Challenges
8.4 Latanoprost Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
